Original Research

Published on 14 Jan 2025

Cellulose nanofiber reinforced curcumin-infused calcium phosphate silicate cement for various bone-tissue engineering application

in Pharmacology of Anti-Cancer Drugs

Xiu Guo Lu
Sha Li Meng
Qiu Jing Zhou
Tao Wu
Xing Tian Gong
Qiong Wu

Frontiers in Oncology

doi 10.3389/fonc.2024.1516638

131 views

Original Research

Published on 10 Jan 2025

Efficacy of PARPi re-maintenance therapy for recurrent ovarian cancer

in Pharmacology of Anti-Cancer Drugs

Yulin Wang
Yunjie Yang
Binghong Guo
Xiaoyan Li
Renakezi Tuersun
Ye Cao
Jundong Li
Jihong Liu
Su Li
Tao Liu

Frontiers in Oncology

doi 10.3389/fonc.2024.1512339

165 views

Systematic Review

Published on 08 Jan 2025

Peritoneal chemotherapy delivery systems for ovarian cancer treatment: systematic review of animal models

in Pharmacology of Anti-Cancer Drugs

Marcelo Simonsen
Rossana Verónica Mendoza López
Simone Maistro
Lucas Takeshi Ikeoka
Glaucia Fernanda de Lima Pereira
Ademar Benévolo Lugão
José Carlos Sadalla
Maria Lúcia Hirata Katayama
Maria Aparecida Azevedo Koike Folgueira

Frontiers in Oncology

doi 10.3389/fonc.2024.1487376

138 views

Original Research

Accepted on 07 Jan 2025

A Pharmacoinformatic Approach for Studying Atractylodes Lancea DC's Anticancer Potential and Control ROS-Mediated Apoptosis Against Prostate Cancer Cells

in Pharmacology of Anti-Cancer Drugs

Kazi Rejvee Ahmed
Ji Soo Myong
Md Ataur Rahman
Md. Maharub Hossain Fahim
Min Choi
Muntajin Rahman
JinWon Choi
Kiryang Kim
Seungjoon Moon
Mohammed DALLI

Frontiers in Oncology

doi 10.3389/fonc.2025.1471110

Review

Published on 07 Jan 2025

Selenium in cancer management: exploring the therapeutic potential

in Pharmacology of Anti-Cancer Drugs

Lingwen He
Lu Zhang
Yulong Peng
Zhijun He

Frontiers in Oncology

doi 10.3389/fonc.2024.1490740

187 views

Review

Accepted on 06 Jan 2025

Advances in the treatment of glioma-related signaling pathways and mechanisms by metformin

in Pharmacology of Anti-Cancer Drugs

Xingyuan Ma
Chao Sun
Xiao Ding
Yuhang Zhang
Tingzhen Deng
Yatao Wang
Haijun Yang
Ruiwen Ding
Haotian Li
Dawen Wang

Frontiers in Oncology

doi 10.3389/fonc.2025.1482050

Review

Accepted on 06 Jan 2025

Homoharringtonine: Mechanisms, Clinical Applications and Research Progress

in Pharmacology of Anti-Cancer Drugs

Wen Wang
Lan He
Ting Lin
Fulan Xiang
Yibin Wu
Fangliang Zhou
Yingchun He

Frontiers in Oncology

doi 10.3389/fonc.2025.1522273

Original Research

Accepted on 06 Jan 2025

Effects of Jianpi Therapy for cancer-related fatigue：a Meta-Analysis of Randomized Controlled Trials

in Pharmacology of Anti-Cancer Drugs

Jiaxing Dai
Huili Shui
Yuan Wu
Huanghui Zhang
Yuanyin Li
Shaowang Zhang
Bing Yang
Dongxin Tang

Frontiers in Oncology

doi 10.3389/fonc.2025.1512460

Review

Accepted on 06 Jan 2025

Review: Performance of jujube and its extracts in cancer: therapeutic, toxicityreducing and potentiating effects

in Pharmacology of Anti-Cancer Drugs

Boyun Gou
Guoqing Chen
Shicong Huang
Na Ning
Qian Gu
Shuai Duan
Yuhua Du
Yi Nan
Ling Yuan

Frontiers in Oncology

doi 10.3389/fonc.2025.1489974

Case Report

Accepted on 30 Dec 2024

Severe cutaneous drug toxicity following disitamab vedotin treatment for metastatic gastric cancer: a case report

in Pharmacology of Anti-Cancer Drugs

Luping Zhao
Victor Cheng
Piaopiao Li

Frontiers in Oncology

doi 10.3389/fonc.2024.1504079

Case Report

Published on 24 Dec 2024

Case report: Eczematous adverse drug reaction after selpercatinib treatment

in Pharmacology of Anti-Cancer Drugs

Bingrun Li
Peng Cao
Wenjing Xu
Litao Zhang

Frontiers in Oncology

doi 10.3389/fonc.2024.1475541

291 views

Review

Published on 16 Dec 2024

Research progress of novel anti-tumor drug formulations

in Pharmacology of Anti-Cancer Drugs

Yan Liu
Qie Guo
YunYan Shi
MengNa Cui
FanBo Jing

Frontiers in Oncology

doi 10.3389/fonc.2024.1507958

373 views

Case Report

Published on 13 Dec 2024

Coexistence of a novel SV2B-ALK, EML4-ALK double-fusion in a lung poorly differentiated adenocarcinoma patient and response to alectinib: a case report and literature review

in Pharmacology of Anti-Cancer Drugs

Huang Chen
Menglan Zhang
Liyan Bai
Yun Niu
Xiaowei Wang
Ruiying Jiang
Ye Wang
Qianqian Feng
Bei Wang
Tingli Dai

Frontiers in Oncology

doi 10.3389/fonc.2024.1453259

421 views

Review

Published on 11 Dec 2024

The antitumor mechanisms of glabridin and drug delivery strategies for enhancing its bioavailability

in Pharmacology of Anti-Cancer Drugs

Chong Li
Yu Wang
Wenjing Zhang
Xiaoman Yang
Yufang Wang
Guanqun Hou
Dongli Wang
Bingbing Han
Yimin Zhang

Frontiers in Oncology

doi 10.3389/fonc.2024.1506588

593 views

Correction

Published on 06 Dec 2024

Corrigendum: CDK4/6 inhibitors improve the anti-tumor efficacy of lenvatinib in hepatocarcinoma cells

in Pharmacology of Anti-Cancer Drugs

Graziana Digiacomo
Claudia Fumarola
Silvia La Monica
Mara Bonelli
Andrea Cavazzoni
Maricla Galetti
Rita Terenziani
Kamal Eltayeb
Francesco Volta
Silvia Zoppi

Frontiers in Oncology

doi 10.3389/fonc.2024.1532291

237 views

Editorial

Published on 06 Dec 2024

Editorial: Photodynamic therapy: challenges and innovations for treating cancer

in Pharmacology of Anti-Cancer Drugs

Newton Soares da Silva
Juliana Ferreira-Strixino
Cristina Pacheco-Soares

Frontiers in Oncology

doi 10.3389/fonc.2024.1526550

247 views

Navigation group

Articles

Cellulose nanofiber reinforced curcumin-infused calcium phosphate silicate cement for various bone-tissue engineering application

Efficacy of PARPi re-maintenance therapy for recurrent ovarian cancer

Peritoneal chemotherapy delivery systems for ovarian cancer treatment: systematic review of animal models

A Pharmacoinformatic Approach for Studying Atractylodes Lancea DC's Anticancer Potential and Control ROS-Mediated Apoptosis Against Prostate Cancer Cells

Selenium in cancer management: exploring the therapeutic potential

Advances in the treatment of glioma-related signaling pathways and mechanisms by metformin

Homoharringtonine: Mechanisms, Clinical Applications and Research Progress

Effects of Jianpi Therapy for cancer-related fatigue：a Meta-Analysis of Randomized Controlled Trials

Review: Performance of jujube and its extracts in cancer: therapeutic, toxicityreducing and potentiating effects

Severe cutaneous drug toxicity following disitamab vedotin treatment for metastatic gastric cancer: a case report

Case report: Eczematous adverse drug reaction after selpercatinib treatment

Research progress of novel anti-tumor drug formulations

Coexistence of a novel SV2B-ALK, EML4-ALK double-fusion in a lung poorly differentiated adenocarcinoma patient and response to alectinib: a case report and literature review

The antitumor mechanisms of glabridin and drug delivery strategies for enhancing its bioavailability

Corrigendum: CDK4/6 inhibitors improve the anti-tumor efficacy of lenvatinib in hepatocarcinoma cells

Editorial: Photodynamic therapy: challenges and innovations for treating cancer